Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00840294 · ClinicalTrials.gov registry record · Phase 3
Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)
A Phase 3 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 3
- Development phase
- 85
- Enrollment target
NCT00840294: Clinical Trial Phase 3 study, sponsored by University of Chicago.
NCT00840294 is a Phase 3 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 85 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00840294, a Phase 3 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of an empiric course of antibiotics for men with an elevated prostate-specific antigen (PSA) level.
Primary Outcome
To assess the impact of ciprofloxacin on the change in PSA from baseline/randomization to prostate biopsy which occurs 21-45 days after randomization. Due to the skewness of the data, the log transformation was used and the outcome used was the log(PSA level post-treatment, at time of biopsy) - log(PSA level baseline).
Interventions
- DRUG Ciprofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
Why NCT00840294 stopped before completion
NCT00840294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Ciprofloxacin is the first listed.
NCT00840294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00840294 about?
NCT00840294 is a clinical study titled "Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)". The purpose of this study is to assess the impact of an empiric course of antibiotics for men with an elevated prostate-specific antigen (PSA) level.
What is the current status of trial NCT00840294?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 85 participants. The study started on 2009-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00840294?
The interventions under investigation include: Ciprofloxacin (DRUG).
Who is sponsoring clinical trial NCT00840294?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00840294's enrollment target sits among peer trials
85 1747th of 2000 higher than 252 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia